Understanding nanomaterial–liver interactions to facilitate the development of safer nanoapplications
Nanomaterials (NMs) are widely used in commercial and medical products, such as
cosmetics, vaccines, and drug carriers. Exposure to NMs via various routes such as dermal …
cosmetics, vaccines, and drug carriers. Exposure to NMs via various routes such as dermal …
Non-alcoholic fatty liver disease and dyslipidemia: an update
N Katsiki, DP Mikhailidis, CS Mantzoros - Metabolism, 2016 - Elsevier
Non-alcoholic fatty liver (NAFLD) is the most common liver disease worldwide, progressing
from simple steatosis to necroinflammation and fibrosis (leading to non-alcoholic …
from simple steatosis to necroinflammation and fibrosis (leading to non-alcoholic …
Objectively assessed cardiorespiratory fitness and all-cause mortality risk: an updated meta-analysis of 37 cohort studies involving 2,258,029 participants
Objective To detail the magnitude and specificity of the association between
cardiorespiratory fitness (CRF) and all-cause mortality risk. Methods Cohort studies with at …
cardiorespiratory fitness (CRF) and all-cause mortality risk. Methods Cohort studies with at …
[HTML][HTML] Erythritol: An in-depth discussion of its potential to be a beneficial dietary component
TA Mazi, KL Stanhope - Nutrients, 2023 - mdpi.com
The sugar alcohol erythritol is a relatively new food ingredient. It is naturally occurring in
plants, however, produced commercially by fermentation. It is also produced endogenously …
plants, however, produced commercially by fermentation. It is also produced endogenously …
Patient-related risk factors for periprosthetic joint infection after total joint arthroplasty: a systematic review and meta-analysis
Background Periprosthetic joint infections (PJIs) are dreaded complications of total joint
arthroplasties. The risk of developing PJIs is likely to be influenced by several patient factors …
arthroplasties. The risk of developing PJIs is likely to be influenced by several patient factors …
Alkaline phosphatase: a novel treatment target for cardiovascular disease in CKD
M Haarhaus, V Brandenburg… - Nature Reviews …, 2017 - nature.com
Cardiovascular disease is the main cause of early death in the settings of chronic kidney
disease (CKD), type 2 diabetes mellitus (T2DM), and ageing. Cardiovascular events can be …
disease (CKD), type 2 diabetes mellitus (T2DM), and ageing. Cardiovascular events can be …
Gamma-glutamyl transferase and the risk of atherosclerosis and coronary heart disease
G Ndrepepa, R Colleran, A Kastrati - Clinica chimica acta, 2018 - Elsevier
Gamma-glutamyl transferase (GGT) is a ubiquitous cell surface enzyme that cleaves
extracellular glutathione (G-SH) or other gamma-glutamyl compounds. GGT serves to …
extracellular glutathione (G-SH) or other gamma-glutamyl compounds. GGT serves to …
Subclassification of obesity for precision prediction of cardiometabolic diseases
Obesity and cardiometabolic disease often, but not always, coincide. Distinguishing
subpopulations within which cardiometabolic risk diverges from the risk expected for a given …
subpopulations within which cardiometabolic risk diverges from the risk expected for a given …
Gamma‐glutamyltransferase—friend or foe within?
SK Kunutsor - Liver International, 2016 - Wiley Online Library
Gamma‐glutamyltransferase (GGT) is a liver enzyme, which is located on the plasma
membranes of most cells and organ tissues, but more commonly in hepatocytes, and is …
membranes of most cells and organ tissues, but more commonly in hepatocytes, and is …
[HTML][HTML] Gamma-glutamyl transferase and cardiovascular disease
G Ndrepepa, A Kastrati - Annals of translational medicine, 2016 - ncbi.nlm.nih.gov
Gamma-glutamyl transferase (GGT) is an enzyme located on the external surface of cellular
membranes. GGT contributes in maintaining the physiological concentrations of cytoplasmic …
membranes. GGT contributes in maintaining the physiological concentrations of cytoplasmic …